CD44 and breast carcinoma: Additionally, nanoparticle-mediated delivery of therapeutic agents, such as doxycycline, has demonstrated significant potential for overcoming MDR in CD44-overexpressing MCF-7 breast cancer cells, offering a promising approach to targeted chemotherapy [142,147].